Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Pain Therapeutics Inc

CUSIP: 69562K950 | 3 institutional holders

Quarters

Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q3 2015

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile